Holen Sie sich die Stockscreener-App
0.00
100.00%
-1.26
Schlusskurs vom Vortag:
$1.26
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$8.60M
Einnahmen:
$129.20K
Nettoeinkommen (Verlust:
$-7.44M
KGV:
0.00
EPS:
-11.19
Netto-Cashflow:
$-8.62M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$3.921
52-Wochen-Spanne:
$0.00
$19.30
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Company Profile
Firmenname
Sonnet Biotherapeutics Holdings Inc
Sektor
Branche
Telefon
609-375-2227
Adresse
100 OVERLOOK CENTER, PRINCETON, NJ
Vergleichen Sie SONN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SONN
Sonnet Biotherapeutics Holdings Inc
|
0.00 | 8.60M | 129.20K | -7.44M | -8.62M | -11.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sonnet Biotherapeutics Holdings Inc Aktie (SONN) Neueste Nachrichten
Officer Kenney Acquires 233,374 Of Sonnet BioTherapeutics Holdings Inc [SONN] - TradingView
Hyperliquid Strategies Moves $411M in HYPE to Hypercore - Live Bitcoin News
Sonnet BioTherapeutics Stockholders Greenlight Hyperliquid Strategies Merger Deal - Blockonomi
Sonnet’s $1B Hype Treasury Signals Ambitious Digital Asset Expansion After Merger Approval - Crypto Economy
Sonnet BioTherapeutics Merges with Hyperliquid Strategies - TipRanks
Is Sonnet BioTherapeutics Holdings Inc. stock attractive for hedge fundsWeekly Trend Summary & Real-Time Buy Zone Alerts - Newser
Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock: Merges Into Hyperliquid Era with Nasdaq Debut as PURR - parameter.io
Sonnet BioTherapeutics Enters a New Frontier with a $1 Billion HYPE Digital Asset Treasury - OneSafe
Sonnet BioTherapeutics shareholders approve proposed business merger with Hyperliquid Strategies Inc. - Bitget
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination - GlobeNewswire
Biotech Trio Gets Hammered On Heavy Trading - Finimize
Sonnet BioTherapeutics Approves Merger with Hyperliquid and Rorschach - MSN
Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock: Shareholders Approve Hyperliquid Merger, Setting Stage for $1B HYPE Treasury - CoinCentral
Revolutionary Shift: How Sonnet BioTherapeutics Became a $305M Digital Asset Treasury Powerhouse - CryptoRank
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Sonnet shareholders approve Hyperliquid merger to launch HYPE-focused crypto treasury - Crypto Briefing
Stockholders Approve Sonnet–Hyperliquid Merger - citybiz
Sonnet shareholders approve merger for potential $1 billion HYPE crypto treasury - theblock.co
Sonnet BioTherapeutics (SONN) Stockholders Approve Business Comb - GuruFocus
Sonnet Biotherapeutics Holdings announces stockholder approval of proposed business combination with Hyperliquid Strategies - marketscreener.com
Sonnet BioTherapeutics shareholders approve business combination - Investing.com
Sonnet BioTherapeutics shareholders approve business combination By Investing.com - Investing.com Australia
Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Business Combination - TradingView
Sonnet BioTherapeutics Stockholders Approve Business Combination with Hyperliquid Strategies Inc and Rorschach I LLC - Quiver Quantitative
Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder - GlobeNewswire
Sonnet BioTherapeutics (NASDAQ: SONN) gets stockholder OK for Hyperliquid Strategies business combination - Stock Titan
Is Sonnet BioTherapeutics Holdings Inc. stock attractive for passive investorsJuly 2025 Rallies & Stepwise Entry/Exit Trade Alerts - Newser
Lowenstein Represents Sonnet BioTherapeutics in Closing of Business Combination with Hyperliquid Strategies - Lowenstein Sandler LLP
Sonnet BioTherapeutics (SONN) Stock Analysis Report | Financials & Insights - Benzinga
Sonnet BioTherapeutics Holdings, Inc.(NasdaqCM:SONN) dropped from NASDAQ Composite Index - marketscreener.com
What drives Sonnet BioTherapeutics Holdings Inc stock priceTrading Psychology Tips & Start Learning With Our Courses - earlytimes.in
Can Sonnet BioTherapeutics Holdings Inc. stock maintain growth trajectoryMarket Risk Summary & Breakout Confirmation Trade Signals - BỘ NỘI VỤ
What analysts say about Sonnet BioTherapeutics Holdings Inc stock - earlytimes.in
Sonnet BioTherapeutics (NASDAQ:SONN) Shares Up 3.2% – Should You Buy? - Defense World
Regression analysis insights on Sonnet BioTherapeutics Holdings Inc. performanceMarket Sentiment Report & AI Based Trade Execution Alerts - newser.com
Why Sonnet BioTherapeutics Holdings Inc. stock could benefit from AI revolution2025 Market Outlook & Weekly High Conviction Ideas - newser.com
Published on: 2025-11-20 06:58:46 - newser.com
Is Sonnet BioTherapeutics Holdings Inc. stock a buy on dipsSell Signal & Precise Swing Trade Entry Alerts - newser.com
Can Sonnet BioTherapeutics Holdings Inc. stock rebound after recent weaknessJuly 2025 EndofMonth & Long-Term Safe Investment Ideas - newser.com
Is Sonnet BioTherapeutics Holdings Inc. stock a good choice for value investors2025 Buyback Activity & Stepwise Entry and Exit Trade Signals - newser.com
Can Sonnet BioTherapeutics Holdings Inc. stock outperform in 2025 bull market - newser.com
What high frequency data says about Sonnet BioTherapeutics Holdings Inc. - newser.com
Using data models to predict Sonnet BioTherapeutics Holdings Inc. stock movementWeekly Investment Summary & Low Risk High Reward Trade Ideas - newser.com
Sentiment analysis tools applied to Sonnet BioTherapeutics Holdings Inc.Portfolio Gains Summary & Free Safe Entry Trade Signal Reports - newser.com
Is Sonnet BioTherapeutics Holdings Inc. meeting your algorithmic filter criteriaJuly 2025 Technicals & Real-Time Volume Triggers - newser.com
How risky is Sonnet BioTherapeutics Holdings Inc. stock nowQuarterly Earnings Summary & Reliable Price Breakout Signals - newser.com
A Fresh $16 Million Bet on ImmunityBio: What Investors Should Know - The Motley Fool
Will Sonnet BioTherapeutics Holdings Inc. stock reach Wall Street targets2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
What momentum shifts mean for Sonnet BioTherapeutics Holdings Inc.Market Trend Report & Fast Exit Strategy with Risk Control - newser.com
Sonnet BioTherapeutics Holdings Inc. (SONN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Sonnet BioTherapeutics Holdings Inc. outperform the marketJuly 2025 EndofMonth & Safe Capital Growth Tips - newser.com
Finanzdaten der Sonnet Biotherapeutics Holdings Inc-Aktie (SONN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.44%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):